Publish Time: 2022-05-25 Origin: Site
Clinical manifestation
The clinical manifestations of pneumonia patients infected with novel coronavirus are: fever, fatigue and dry cough are the main manifestations, nasal congestion, runny nose and other upper respiratory symptoms are rare, and hypoxia will occur. About half of the patients developed dyspnea more than one week later, and the severe cases rapidly progressed to acute respiratory distress syndrome, septic shock, metabolic acidosis that was difficult to correct, and bleeding and coagulation dysfunction. It is worth noting that patients with severe and critical diseases can have moderate and low fever in the course of disease, or even no obvious fever. Some patients have mild symptoms, but no fever, and most of them recover after 1 week. Most patients recovered well, and a few patients were critically ill or even died.
Treatment technology
The eight anti epidemic science and technology breakthrough commandos are: patient prevention detection and diagnosis
In December, 2021, the new crown monoclonal neutralizing antibody ambavir / romisvir combination therapy, which was developed by Professor zhanglinqi, Professor of Tsinghua University School of medicine and director of Tsinghua University Global Health and infectious disease research center and AIDS comprehensive research center, was approved by the China National Drug Administration on December 8, It is used to treat patients with mild and common novel coronavirus infection (covid-19) in adults and adolescents (12-17 years old, weight ≥ 40kg) with high risk factors for progression to severe (including hospitalization or death). Among them, adolescents (12-17 years old, weight ≥ 40kg) with indications are approved with conditions.
Diagnosis and treatment plan
After the outbreak of pneumonia infected by novel coronavirus, the National Health Commission issued the diagnosis and treatment plan for novel coronavirus pneumonia, and organized experts to revise the diagnosis and treatment plan in time on the basis of analyzing, judging and summarizing the early medical treatment work by analyzing the epidemic situation and research progress.
On January 16, 2020, the diagnosis and treatment plan for pneumonia infected by novel coronavirus (Trial) was released. The diagnosis and treatment plan for pneumonia infected by novel coronavirus (trial version 2) was also released later.
On January 22nd, 2020, the general office of the National Health Commission and the office of the State Administration of traditional Chinese Medicine released the diagnosis and treatment plan for pneumonia infected by novel coronavirus (trial version 3).
On January 27th, 2020, the general office of the National Health Commission and the office of the State Administration of traditional Chinese Medicine released the diagnosis and treatment plan for pneumonia infected by novel coronavirus (trial version 4).
On February 4, 2020, the general office of the National Health Commission and the office of the State Administration of traditional Chinese medicine jointly issued the diagnosis and treatment plan for pneumonia infected by novel coronavirus (trial version 5) [27]. On February 8, the general office of the National Health Commission and the office of the State Administration of traditional Chinese Medicine released the diagnosis and treatment plan for novel coronavirus pneumonia (trial version 5, revised version).
On February 14, 2020, the general office of the National Health Commission and the office of the State Administration of traditional Chinese medicine jointly issued the diagnosis and treatment plan for severe and critical cases of novel coronavirus pneumonia (trial version 2).
On February 19, 2020, the general office of the National Health Commission and the office of the State Administration of traditional Chinese medicine jointly issued the diagnosis and treatment plan for novel coronavirus pneumonia (trial version 6).
On March 4, 2020, the general office of the National Health Commission and the office of the State Administration of traditional Chinese medicine jointly issued the diagnosis and treatment plan for novel coronavirus pneumonia (trial version 7).
On August 18, 2020, the general office of the National Health Commission and the office of the State Administration of traditional Chinese medicine jointly issued the diagnosis and treatment plan for novel coronavirus pneumonia (trial version 8).
On February 11, 2022, the novel coronavirus therapeutic drug namatvir tablets / ritonavir tablets combination package (paxlovid) was an oral small molecule novel coronavirus therapeutic drug, which was used to treat adults with mild to moderate novel coronavirus pneumonia (covid-19) with severe high-risk factors.
Leave your email address, we will send professional service personnel to establish communication with you.
During the period, we will strictly comply with the terms of stealth service to ensure your information security.